Application 203959
- Type
- ANDA
- Sponsor
- WATSON LABS TEVA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TEMOZOLOMIDE | TEMOZOLOMIDE | CAPSULE;ORAL | 5MG | No | No |
| 002 | TEMOZOLOMIDE | TEMOZOLOMIDE | CAPSULE;ORAL | 20MG | No | No |
| 003 | TEMOZOLOMIDE | TEMOZOLOMIDE | CAPSULE;ORAL | 100MG | No | No |
| 004 | TEMOZOLOMIDE | TEMOZOLOMIDE | CAPSULE;ORAL | 140MG | No | No |
| 005 | TEMOZOLOMIDE | TEMOZOLOMIDE | CAPSULE;ORAL | 250MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A203959-001 | TEMOZOLOMIDE | TEMOZOLOMIDE | 5MG | CAPSULE / ORAL | 2017-04-18 | ||
| A203959-002 | TEMOZOLOMIDE | TEMOZOLOMIDE | 20MG | CAPSULE / ORAL | 2017-04-18 | ||
| A203959-003 | TEMOZOLOMIDE | TEMOZOLOMIDE | 100MG | CAPSULE / ORAL | 2017-04-18 | ||
| A203959-004 | TEMOZOLOMIDE | TEMOZOLOMIDE | 140MG | CAPSULE / ORAL | 2017-04-18 | ||
| A203959-005 | TEMOZOLOMIDE | TEMOZOLOMIDE | 250MG | CAPSULE / ORAL | 2017-04-18 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A203959-001 | TEMOZOLOMIDE | 5MG | CAPSULE / ORAL | 2017-04-18 | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | A203959-002 | TEMOZOLOMIDE | 20MG | CAPSULE / ORAL | 2017-04-18 | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | A203959-003 | TEMOZOLOMIDE | 100MG | CAPSULE / ORAL | 2017-04-18 | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | A203959-004 | TEMOZOLOMIDE | 140MG | CAPSULE / ORAL | 2017-04-18 | a50c72e98297… | ||
| 2026-08-01 22:54:32 | 2026-06 | A203959-005 | TEMOZOLOMIDE | 250MG | CAPSULE / ORAL | 2017-04-18 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Temozolomide | TEMOZOLOMIDE | OPKO Pharmaceuticals, LLC | 9dff10ec-6a55-47b6-a458-b7c39e32dc55 | 2026-07-27 | Warnings, Adverse reactions | Temozolomide TEMOZOLOMIDE |
| Temozolomide | TEMOZOLOMIDE | OPKO Pharmaceuticals, LLC | f6d762ea-fff0-43e8-b67d-bef19e883dd8 | 2026-07-27 | Warnings, Adverse reactions | Temozolomide TEMOZOLOMIDE |
| Temozolomide | TEMOZOLOMIDE | OPKO Pharmaceuticals, LLC | f743f7e0-74cf-47e5-bf21-f2b75d2596dc | 2026-07-27 | Warnings, Adverse reactions | Temozolomide TEMOZOLOMIDE |
| Temozolomide | TEMOZOLOMIDE | OPKO Pharmaceuticals, LLC | b3f69c67-db30-4266-8075-9b18c71c9fc1 | 2026-07-27 | Warnings, Adverse reactions | Temozolomide TEMOZOLOMIDE |
| Temozolomide | TEMOZOLOMIDE | Bryant Ranch Prepack | 79766855-2533-43b1-b60e-1e9daecadad5 | 2026-06-09 | Warnings, Adverse reactions | Temozolomide TEMOZOLOMIDE |
| Temozolomide | TEMOZOLOMIDE | Bryant Ranch Prepack | 021b97cc-a76f-44b6-b7be-670d2ae83690 | 2026-06-09 | Warnings, Adverse reactions | Temozolomide TEMOZOLOMIDE |
| Temozolomide | TEMOZOLOMIDE | Bryant Ranch Prepack | c0f2077c-48e6-452e-9f88-e1f2c89df0a2 | 2026-06-09 | Warnings, Adverse reactions | Temozolomide TEMOZOLOMIDE |
| Temozolomide | TEMOZOLOMIDE | Bryant Ranch Prepack | 38f17780-8037-44a0-9e84-b7150c9bde12 | 2026-06-09 | Warnings, Adverse reactions | Temozolomide TEMOZOLOMIDE |
| Temozolomide | TEMOZOLOMIDE | Bryant Ranch Prepack | 6eb0bd33-582f-43a6-a607-e72b4390c6d3 | 2026-06-09 | Warnings, Adverse reactions | Temozolomide TEMOZOLOMIDE |
| Temozolomide | TEMOZOLOMIDE | Bryant Ranch Prepack | a147b361-262c-49c6-9b8e-7e454f755721 | 2026-06-09 | Warnings, Adverse reactions | Temozolomide TEMOZOLOMIDE |
| Temozolomide | TEMOZOLOMIDE | CivicaScript LLC | 56245d21-4a42-471e-bbdc-80b129336e2f | 2026-04-28 | Warnings, Adverse reactions | Temozolomide TEMOZOLOMIDE |
| TEMODAR | TEMOZOLOMIDE | Merck Sharp & Dohme LLC | 046a9011-3911-4d3f-a15f-fbb56d5aad56 | 2026-02-20 | Warnings, Adverse reactions | TEMOZOLOMIDE |
| Temozolomide | TEMOZOLOMIDE | Sun Pharmaceutical Industries, Inc. | c1e05c21-a411-4493-80de-ede373632475 | 2025-11-14 | Warnings, Adverse reactions | Temozolomide TEMOZOLOMIDE |
| Temozolomide | TEMOZOLOMIDE | Accord Healthcare Inc. | 2d599ccf-8e63-4ff1-aa52-4809744ea97a | 2025-05-23 | Warnings, Adverse reactions | Temozolomide TEMOZOLOMIDE |
| Temozolomide | TEMOZOLOMIDE | Ascend Laboratories, LLC | 33d67bce-38ae-45fc-a858-d51167b0ecfd | 2025-01-09 | Warnings, Adverse reactions | Temozolomide TEMOZOLOMIDE |
| Temozolomide | TEMOZOLOMIDE | Devatis, Inc. | 6b263fe0-5f06-4889-bf14-4aa185470810 | 2024-11-30 | Warnings, Adverse reactions | Temozolomide TEMOZOLOMIDE |
| TEMOZOLOMIDE | TEMOZOLOMIDE | Camber Pharmaceuticals, Inc. | 78c12889-c837-40c1-8f85-4d048008ad29 | 2024-10-19 | Warnings, Adverse reactions | TEMOZOLOMIDE TEMOZOLOMIDE |
| TEMOZOLOMIDE | TEMOZOLOMIDE | Rising Pharma Holdings, Inc. | 70996a9d-4a4f-4ed1-ab07-130486aa14ab | 2024-07-25 | Warnings, Adverse reactions | TEMOZOLOMIDE TEMOZOLOMIDE |
| Temozolomide | TEMOZOLOMIDE | Amneal Pharmaceuticals LLC | 6c8529ec-8936-4fec-a1a5-2b285c7e4859 | 2024-02-17 | Warnings, Adverse reactions | Temozolomide TEMOZOLOMIDE |
| temozolomide | TEMOZOLOMIDE | Nivagen Pharmaceuticals, Inc. | 27e5a781-e4f2-4489-9def-7971d0b86d9c | 2021-11-28 | Boxed warning, Warnings, Adverse reactions | temozolomide TEMOZOLOMIDE |